{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:32:32Z","timestamp":1790674352800,"version":"4.1.0"},"reference-count":16,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T00:00:00Z","timestamp":1312848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cutaneous malignant melanoma (CMM) is an etiologically heterogeneous disease with genetic, environmental (sun exposure) and host (pigmentation\/nevi) factors and their interactions contributing to risk. Genetic variants in DNA repair genes may be particularly important since their altered function in response to sun exposure\u2010related DNA damage maybe related to risk for CMM. However, systematic evaluations of genetic variants in DNA repair genes are limited, particularly in high\u2010risk families. We comprehensively analyzed DNA repair gene polymorphisms and CMM risk in melanoma\u2010prone families with\/without CDKN2A mutations. A total of 586 individuals (183 CMM) from 53 families (23 CDKN2A (+), 30 CDKN2A (\u2212)) were genotyped for 2964 tagSNPs in 131 DNA repair genes. Conditional logistic regression, conditioning on families, was used to estimate trend\n                    <jats:italic>p<\/jats:italic>\n                    \u2010values, odds ratios and 95% confidence intervals for the association between CMM and each SNP separately, adjusted for age and sex.\n                    <jats:italic>p<\/jats:italic>\n                    \u2010Values for SNPs in the same gene were combined to yield gene specific\n                    <jats:italic>p<\/jats:italic>\n                    \u2010values. Two genes, POLN and PRKDC, were significantly associated with melanoma after Bonferroni correction for multiple testing (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.0003 and 0.00035, respectively). DCLRE1B showed suggestive association (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.0006). 28 \u223c 56% of genotyped SNPs in these genes had single SNP\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.05. The most significant SNPs in POLN and PRKDC had similar effects in CDKN2A (+) and CDKN2A (\u2212) families. Our finding suggests that polymorphisms in DNA repair genes, POLN and PRKDC, were associated with increased melanoma risk in melanoma families with and without CDKN2A mutations.\n                  <\/jats:p>","DOI":"10.1002\/ijc.26231","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T20:21:19Z","timestamp":1307996479000},"page":"2062-2066","source":"Crossref","is-referenced-by-count":22,"title":["Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma\u2010prone families with\/without CDKN2A mutations"],"prefix":"10.1002","volume":"130","author":[{"given":"Xueying Sharon","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chanock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa M.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong R.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9247"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-05-0321A","article-title":"Association of MC1R variants and risk of melanoma in melanoma\u2010prone families with CDKN2A mutations","volume":"14","author":"Goldstein A","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/323411"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206444"},{"key":"e_1_2_6_6_2","volume-title":"Cutaneous malignant melanoma","author":"Armstrong BK","year":"1996"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqn170"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp207"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2005.03.007"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.12.1006"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/88.4.933"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24622"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.10264"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.20422"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.04.049"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.11.8605"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01124-09"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.26231","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.26231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T14:54:36Z","timestamp":1697468076000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.26231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1002\/ijc.26231"],"URL":"https:\/\/doi.org\/10.1002\/ijc.26231","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,9]]}}}